Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...
A federal judge has thrown out Amgen’s lawsuit against the state board empowered to set price ceilings on prescription drugs ...
Amgen is a leading biopharmaceutical company that develops innovative medicines in areas with significant unmet needs. Read ...
A single dose of an experimental drug dramatically reduced levels of a deadly form of cholesterol, often thought to be ...
Amgen had argued the board is unconstitutional because its actions conflict with federal law and would regulate business ...
In the coming two weeks, the FDA is expected to announce three big decisions, including one for a dry eye disease therapy.
Judge tosses Amgen's challenge to Colorado drug review board, says suit is 'too speculative'
A federal judge on Friday dismissed Amgen’s lawsuit against Colorado's drug affordability board and its decision to place a price cap on the company's blockbuster autoimmune drug.
Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
A federal judge has dismissed Amgen’s lawsuit against Colorado’s Prescription Drug Affordability Board, allowing the state to move forward with setting price ceilings on prescription drugs, The Denver ...
The experimental drug lepodisiran, developed by Eli Lilly, significantly lowered levels of the genetically inherited heart ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback